Friday, September 9, 2022

IOL Chemicals & Pharmaceuticals Ltd(524164)- Doubling revenue in next four years

IOL Chemicals & Pharmaceuticals Ltd(524164)  closes   at 381.75  with  a   Gain of   +2.6%   on    on    07-September-2022  with formation of  a  Green   Candle    on Daily  Price Chart.

About the Company : IOL Chemicals & Pharmaceuticals Ltd is a leading pharmaceutical (APIs) company and is a significant player in the specialty chemicals space. It serves the domestic and export market. It is the largest player of Ibuprofen (pain killer) globally with a world market share of 35%

Sector Update :  Positive

Refinitiv  Average Score : 05/ 10

Financials : IOL Chemicals & Pharmaceuticals Ltd  has posted Net Sales / Revenue   of 2184.00 Cr & Net Profit of   166.0 Cr in FY2022 and expected to post Net Sales / Revenue   of 2450.00 Cr (+12%) & Net Profit of 221.72 Cr in FY2023  & Net Sales / Revenue   of 2630.00 ( +20.5%) Cr & Net Profit of 238.01Cr in FY2024.

Valuations  : The Company is now Trading at X1.70 of its  valuations of  FY2022 (Last 4 Quarters ) earnings with ~70% premium ;  at X0.75 of its FY2023 earnings with ~25%  Discount and at X0.70 of its FY2023 earnings with ~30%  Discount

EPS  will  improve from 22.80  in FY2022 to 44.450  in FY2024  .

Early Trend : As part of de-risking their business, Cos has started reducing the share of ibuprofen in their overall turnover, and add more popular products to the portfolio. It is spending Rs 100-150 crore in capex every year, and is adding production lines at its Barnala plant which is spread over 100 acres.


Margin of Safety (1Yr Bond Yield: Value>1 ) is now  0.70   which  makes is attractive .The  Equity Value Per Share ( Enterprise Value Method ) is  358.00

If We factor its FY2023 earnings/valuations, its Price arrives at 928.00


Disclaimer : We are / may going to take exposure shortly.

Join Us at   Telegram #

Data Source NSE Website | Screener.In  | Capital Line Money Control |Refinitiv |

The author tracks economic, behavioural and corporate tends, hoping to gauge good avenues of return based on Fundamental Valuations of Stocks, a follower of EPV method. You can reach me/us at | Twitter # NiftyNext1 |  e-Mail : Mail@NiftyNext.Com  |  Tel +91 8802230836  |  Telegram # TheNiftyNext  Manage your investments the right way With MProfit. Visit https://www.mprofit.inUse Our Referral Link to Get 20% DISCOUNT @


No comments:

Post a Comment

Thanks for Your Valuable comments. It will make Us to Serve You in Better Way. For Any STOCKS Query ,Please Call NiftyNext +91 880 2230 836.


The recommendations made herein do not constitute an offer to sell or a solicitation to buy any of the securities mentioned. No representations can be made that the recommendations contained herein will be profitable or that they will not result in losses. Readers using the information contained herein are solely responsible for their actions. Information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on the theory of Technical Analysis and do not reflect the fundamental validity of the Scrip. does 't take any Responsibility for any losses arising from using the Stocks Recommendations.
We( WWW.NIFTYNEXT.COM) are not Registered with Any Regulatory Body in India ie SEBI,NSE,BSE,AMFI or Any Otheres.

Blog Archive